Patricia Tarilonte
Alcobendas, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 04, 2025
Cost analysis of transthyretin amyloid cardiomyopathy in heart failure patients with preserved ejection fraction in Spain.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: February 05, 2025
Management of Hereditary Transthyretin Amyloidosis (ATTRv) Patients and Asymptomatic Carriers in Spain: The EMPATIa Study.
Journal: Journal of clinical medicine
Published: October 11, 2024
Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study.
Journal: Revista espanola de cardiologia (English ed.)
Published: April 30, 2024
Assessment of incidental cardiac uptake in bone scintigraphy across Spain: The ECCINGO study.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: April 29, 2024
A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study.
Journal: Orphanet journal of rare diseases
Published: May 10, 2023
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 28, 2021
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 16, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026